Home › Funds › 5439 Payden Equity Income Fund
Fund family: PAYDEN & RYGEL INVESTMENT GROUP · Filed by PAYDEN & RYGEL INVESTMENT GROUP (CIK 885709) · SEC series S000011766
Share classes and tickers: PYVAX (C000110231), PYVLX (C000032191), PYVSX (C000146917)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 952 with, 85 against, 22 abstentions (not counted as with management). Shareholder proposals: 37 FOR, 48 AGAINST, 21 abstained, by the filing’s own vote-source field.
No item-level comparison with other PAYDEN & RYGEL INVESTMENT GROUP funds is possible: fewer than three other funds of the family voted in 2025-2026.
The same votes as “with management” above, by the sector of the company voted on. 94.8% of this fund’s 1,059 such votes could be given a sector; the other 55 (5.2%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Technology | 188 | 28 | 14.9% |
| Consumer Discretionary | 160 | 23 | 14.4% |
| Finance | 158 | 8 | 5.1% |
| Industrials | 156 | 4 | 2.6% |
| Health Care | 112 | 10 | 8.9% |
| Utilities | 57 | 3 | 5.3% |
| Real Estate | 52 | 1 | 1.9% |
| Consumer Staples | 49 | 2 | 4.1% |
| Energy | 29 | 3 | 10.3% |
| Telecommunications | 28 | 2 | 7.1% |
| Basic Materials | 15 | 1 | 6.7% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 748 | 0 |
| Audit-related | 73 | 0 |
| Say-on-Pay | 67 | 0 |
| Corporate Governance | 35 | 22 |
| Capital Structure | 30 | 1 |
| Compensation | 26 | 5 |
| Other Social Issues | 23 | 14 |
| Environment or Climate | 19 | 11 |
| Human Rights or Human Capital/workforce | 15 | 13 |
| Shareholder Rights and Defenses | 15 | 13 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Alphabet Inc. | June 5, 2026 | $37M | 23 | 0 |
| JPMorgan Chase & Co. | May 19, 2026 | $35M | 17 | 1 |
| McKesson Corporation | July 30, 2025 | $31M | 14 | 0 |
| Amazon.com, Inc. | May 20, 2026 | $30M | 17 | 4 |
| Merck & Co., Inc. | May 26, 2026 | $27M | 18 | 3 |
| Morgan Stanley | May 14, 2026 | $27M | 18 | 1 |
| Analog Devices, Inc. | March 11, 2026 | $24M | 14 | 1 |
| Cisco Systems, Inc. | December 16, 2025 | $24M | 13 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 19, 2026 | JPMorgan Chase & Co. | Independent board chairman Shareholder proposal | For | Against |
| May 20, 2026 | Amazon.com, Inc. | Shareholder Proposal Requesting A Report On Charitable Partnerships Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | Shareholder Proposal Requesting Additional Reporting On Impact Of Data Centers On Climate Commitments Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| May 14, 2026 | Morgan Stanley | Shareholder proposal requesting an independent Board Chairman Shareholder proposal | For | Against |
| March 11, 2026 | Analog Devices, Inc. | To consider a shareholder proposal, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| May 27, 2026 | Chevron Corporation | Adopt an Independent Chair Shareholder proposal | For | Against |
| May 27, 2026 | Chevron Corporation | Report on Indigenous Peoples Rights Shareholder proposal | Against | For |
| May 5, 2026 | GE Aerospace | Shareholder Proposal Regarding Right to Act by Written Consent Shareholder proposal | For | Against |
| May 5, 2026 | GE Aerospace | Shareholder Proposal Requesting Report on Defense-Related Products Shareholder proposal | Against | For |
| May 14, 2026 | CVS Health Corporation | Stockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposal | For | Against |
1,061 ballot items at 70 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, 5439 Payden Equity Income Fund (PYVAX) voted at 70 shareholder meetings of 69 companies, on 1,061 ballot items in all. Where management made a recommendation, the fund followed it on 89.9% of the items and voted against it 85 times. Its most frequent area of disagreement was corporate governance (22 of its votes against management). It voted FOR 43.5% of the 85 shareholder proposals on which it cast a FOR or AGAINST vote.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.